Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antifungal drug
Biotech
F2G raises $100M for 2nd attempt to get new antifungal to market
The money is earmarked for late-stage development of olorofim, as well as seeking regulatory approval and preparing for commercialization in the U.S.
James Waldron
Sep 12, 2024 8:58am
Pulmocide exits OPERA with evidence of antifungal efficacy
Apr 15, 2024 9:41am
Drug has power of nature's strongest antibiotic, but less toxic
Nov 9, 2023 10:30am
Cidara wins near-unanimous AdComm support despite data doubts
Jan 25, 2023 10:17am
Shionogi splashes $100M on F2G's rare fungal disease drug
May 16, 2022 5:28am
Pfizer buys Amplyx to grow infectious disease pipeline
Apr 28, 2021 7:45am
